The 2022 outbreak of monkeypox reignited discussions around the importance of safety and transparency in high-containment laboratory research—particularly in international contexts. While early cases in Europe were epidemiologically linked to West Africa, scientific studies and broader reporting have pointed to the need for stronger oversight and clearer communication regarding overseas biomedical research involving high-risk pathogens.… MoreMonkeypox, Biosafety, and Lessons in Global Laboratory OversightRead More
Monkeypox, Biosafety, and Lessons in Global Laboratory Oversight
By Digital Team
